Changeflow GovPing Healthcare Variance Approval to VarsIQ Media
Routine Rule Added Final

Variance Approval to VarsIQ Media

Email

Summary

The FDA Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to VarsIQ Media. Variances are exemptions or waivers from specific regulatory requirements under the Federal Food, Drug, and Cosmetic Act. This approval modifies the applicable regulatory requirements for VarsIQ Media, allowing deviation from certain standard CDRH requirements.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The FDA Center for Devices and Radiological Health granted a variance approval to VarsIQ Media. A variance is an official exemption from specific regulatory requirements that would otherwise apply to the company under FDA's device regulations. The variance approval letter modifies the standard compliance obligations for VarsIQ Media.

VarsIQ Media should maintain the variance approval letter on file and ensure compliance with any conditions specified in the approval. Companies engaging with FDA CDRH on device-related matters should review whether similar variance relief may be available for their operations. Regulatory affairs personnel should document variance approvals as part of their compliance documentation.

Archived snapshot

Apr 18, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 1

Variance Approval Letter to VarsIQ Media

More Information
- Author(s) CDRH
Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
FDA-2026-V-3708-0003
Docket
FDA-2026-V-3708

Who this affects

Applies to
Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Variance approval Regulatory exemptions Device compliance
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Regulatory Affairs
Compliance frameworks
GxP
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!